dvm360 product report: Transdermal mirtazapine, equine flu vaccines and more

dvm360 product report: Transdermal mirtazapine, equine flu vaccines and more

Here’s our regular roundup of new and noteworthy veterinary products.
source-image
Jun 08, 2018
By dvm360.com staff

KindredBio

Transdermal medication to manage feline weight loss

Mirataz (mirtazapine ointment) is a transdermal medication specifically developed and FDA-approved to manage undesired weight loss in cats—a leading cause of visits to the veterinarian. Mirataz, which is formulated with KindredBio's proprietary Accusorb technology, is applied topically to the cat's inner ear (pinna) once a day, providing a more convenient application route than oral administration.

Read more here.

 

Merck

Equine flu vaccines

The Prestige line of influenza vaccines offers the next generation equine influenza protection. It meets current World Organization for Animal Health and American Association of Equine Practitioners guidelines for clade 1 and clade 2 strains. Influenza vaccination is recommended at six-month intervals for any performance, show or pleasure horses at risk of exposure, including resident horses exposed to traveling horses.

Read more here.

 

Brakke

Pain products market study

This study, Pain Management Products for Dogs and Cats, profiles the veterinary market for analgesics, both veterinary and human products, as well as nutritional supplements, therapeutic diets for joint support and complementary therapies. The report includes an overview of pain management in veterinary medicine, leading product sales and pricing, and a discussion of new and developing products, as well as a number of novel molecules.

Read more here.